USD29.79
A vial is not a strategy Labelling:Unbranded https://5.imimg.com/data5/SELLER/Default/2025/12/565960914/QC/DA/ST/93007977/vib-12-1000mcg-injection-500x500.jpg In-Vitro Research Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis | Neurology
USD29.79
USD21.30
USD29.32
USD20.58
USD29.47
USD25.78
USD22.68
Review the final selection for any optional recurring feature. Distinguish routine product care from a contractual or payment obligation.
Keep the original intended specification clear in your message. Do not assume closing the page cancels an order already created.
Write a short summary of the specific points you understood. State the selected option explicitly if several were discussed.